Non-melanoma skin cancer treated with HDR Valencia applicator: clinical outcomes

被引:64
作者
Tormo, Alejandro [1 ]
Celada, Francisco [1 ]
Rodriguez, Silvia [2 ]
Botella, Rafael [3 ]
Ballesta, Antonio [1 ]
Kasper, Michael [4 ]
Ouhib, Zoubir
Santos, Manuel [2 ]
Perez-Calatayud, Jose [2 ,5 ]
机构
[1] La Fe Univ Hosp, Dept Radiotherapy, Valencia, Spain
[2] Benidorm Hosp, Dept Radiotherapy, Alicante, Spain
[3] La Fe Univ & Polytech Hosp, Dept Dermatol, Valencia, Spain
[4] Lynn Reg Canc Ctr, Boca Raton, FL USA
[5] La Fe Univ Hosp, Dept Radiat Oncol, Phys Sect, Valencia, Spain
关键词
HDR; skin brachytherapy; skin cancer; Valencia applicators; DOSE-RATE BRACHYTHERAPY; SURFACE APPLICATORS; CARCINOMA; MOLDS; SURGERY; THERAPY; MARGINS;
D O I
10.5114/jcb.2014.43247
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Radiotherapy (RT) has played a significant role in treating non melanoma skin cancer (NMSC). High-dose-rate brachytherapy (HDR-BT) approaches have a paramount relevance due to their adaptability, patient protection, and variable dose fractionation schedules. Several innovative applicators have been introduced to the brachytherapy community. The Valencia applicator is a new superficial device that improves the dose distribution compared with the Leipzig applicator. The purpose of this work is to assess the tumor control, cosmesis, and toxicity in patients with NMSC treated with the Valencia applicator and a new regimen of hypofractionation. Material and methods: From January 2008 to March 2010, 32 patients with 45 NMSC lesions were treated with the Valencia applicator in the Hospital La Fe. The gross tumor volume was visually assessed, but the tumor depth was evaluated using ultrasound imaging. All lesions for the selected cases were limited to 4 mm depth. The prescription dose was 42 Gy in 6 or 7 fractions (biologically effective dose [BED] approximate to 70 Gy), delivered twice a week. Results: Ninety-eight percent of the lesions were locally controlled at 47 months from treatment. Ninety-three percent of patients were out at least 36 months from treatment. The treatment was well tolerated in all cases. The highest skin toxicity was grade 1 RTOG/EORTC, having resolved with topical treatment at 4 weeks in all but one case which required 2 months. There were no grade 2 or higher late adverse events. Conclusions: In patients with superficial basal cell carcinoma lesions less than 25 mm in maximum diameter, HDRBT treatment with the Valencia applicator using a hypofractionated regimen provides excellent results, for both cosmetic and local control at a minimum of 3 years follow-up. Moreover, the shorter hypofractionated regimen facilitates compliance, which is very relevant for the elderly patients in our series. Valencia applicators offer a simple, safe, quick, and attractive nonsurgical treatment option.
引用
收藏
页码:167 / 172
页数:6
相关论文
共 36 条
  • [21] Treatment of Nonfatal Conditions at the End of Life Nonmelanoma Skin Cancer
    Linos, Eleni
    Parvataneni, Rupa
    Stuart, Sarah E.
    Boscardin, W. John
    Landefeld, C. Seth
    Chren, Mary-Margaret
    [J]. JAMA INTERNAL MEDICINE, 2013, 173 (11) : 1006 - 1012
  • [22] A systematic review of worldwide incidence of nonmelanoma skin cancer
    Lomas, A.
    Leonardi-Bee, J.
    Bath-Hextall, F.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2012, 166 (05) : 1069 - 1080
  • [23] LOVETT RD, 1990, INT J RADIAT ONCOL, V19, P235, DOI 10.1016/0360-3016(90)90529-S
  • [24] Sevenyears' experience of Mohs micrographic surgery in a UK centre, and development of a UK minimum dataset and audit standards
    Macfarlane, L.
    Waters, A.
    Evans, A.
    Affleck, A.
    Fleming, C.
    [J]. CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2013, 38 (03) : 262 - 269
  • [25] Treatment of facial cutaneous carcinoma with high-dose rate contact brachytherapy with customized molds
    Maronas, Maria
    Luis Guinot, Jose
    Arribas, Leoncio
    Carrascosa, Maria
    Isabel Tortajada, Maria
    Carmona, Ruth
    Estornell, Marian
    Muelas, Rodrigo
    [J]. BRACHYTHERAPY, 2011, 10 (03) : 221 - 227
  • [26] High-dose-rate (HDR) plesiotherapy with custom-made moulds for the treatment of non-melanoma skin cancer
    Montero, Angel
    Hernanz, Raul
    Capuz, Ana-Belen
    Fernandez, Eva
    Hervas, Asuncion
    Colmenares, Rafael
    Polo, Alfredo
    Sancho, Sonsoles
    Moleron, Rafael
    Vallejo, Carmen
    Ramos, Alfredo
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (11) : 760 - 764
  • [27] NCI NIH DHHS, 2009, NIH PUBL
  • [28] Dosimetric characteristics of the Leipzig surface applicators used in the high dose rate brachy radiotherapy
    Niu, H
    Hsi, WC
    Chu, JCH
    Kirk, MC
    Kouwenhoven, E
    [J]. MEDICAL PHYSICS, 2004, 31 (12) : 3372 - 3377
  • [29] Mold brachytherapy can be an optional technique for total scalp irradiation
    Özyar, E
    Gurdalli, S
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (04): : 1286 - 1286
  • [30] A dosimetric study of Leipzig applicators
    Pérez-Calatayud, J
    Granero, D
    Ballester, F
    Puchades, V
    Casal, E
    Soriano, A
    Crispin, V
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (02): : 579 - 584